<!-- Elements added to main will be displayed on all pages --> <!doctype html><html lang=en class=no-js> <head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta name=description content="What you need to know about Alemtuzumab, also known as Campath 1H, MabCampath"><meta name=author content=Ramon><link href=https://immunowiki.com/patient-information/alemtuzumab/ rel=canonical><link href=../acute-urticaria/ rel=prev><link href=../allergic-rhinitis/ rel=next><link rel=icon href=../../assets/images/favicon.png><meta name=generator content="mkdocs-1.5.3, mkdocs-material-9.5.5"><title>Alemtuzumab - Immunowiki</title><link rel=stylesheet href=../../assets/stylesheets/main.50c56a3b.min.css><link rel=stylesheet href=../../assets/stylesheets/palette.06af60db.min.css><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback"><style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style><link rel=stylesheet href=../../stylesheets/extra.css><script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script></head> <body dir=ltr data-md-color-scheme=default data-md-color-primary=indigo data-md-color-accent=indigo> <input class=md-toggle data-md-toggle=drawer type=checkbox id=__drawer autocomplete=off> <input class=md-toggle data-md-toggle=search type=checkbox id=__search autocomplete=off> <label class=md-overlay for=__drawer></label> <div data-md-component=skip> <a href=#why-is-alemtuzumab-being-recommended-in-my-condition class=md-skip> Skip to content </a> </div> <div data-md-component=announce> <aside class=md-banner> <div class="md-banner__inner md-grid md-typeset"> <button class="md-banner__button md-icon" aria-label="Don't show this again"> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg> </button> This website contains general medical information which is not advice and should not be treated as such. </div> <script>var content,el=document.querySelector("[data-md-component=announce]");el&&(content=el.querySelector(".md-typeset"),__md_hash(content.innerHTML)===__md_get("__announce")&&(el.hidden=!0))</script> </aside> </div> <header class=md-header data-md-component=header> <nav class="md-header__inner md-grid" aria-label=Header> <a href=../.. title=Immunowiki class="md-header__button md-logo" aria-label=Immunowiki data-md-component=logo> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M13 12h7v1.5h-7m0-4h7V11h-7m0 3.5h7V16h-7m8-12H3a2 2 0 0 0-2 2v13a2 2 0 0 0 2 2h18a2 2 0 0 0 2-2V6a2 2 0 0 0-2-2m0 15h-9V6h9"/></svg> </a> <label class="md-header__button md-icon" for=__drawer> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg> </label> <div class=md-header__title data-md-component=header-title> <div class=md-header__ellipsis> <div class=md-header__topic> <span class=md-ellipsis> Immunowiki </span> </div> <div class=md-header__topic data-md-component=header-topic> <span class=md-ellipsis> Alemtuzumab </span> </div> </div> </div> <form class=md-header__option data-md-component=palette> <input class=md-option data-md-color-media data-md-color-scheme=default data-md-color-primary=indigo data-md-color-accent=indigo aria-label="Switch to dark mode" type=radio name=__palette id=__palette_0> <label class="md-header__button md-icon" title="Switch to dark mode" for=__palette_1 hidden> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg> </label> <input class=md-option data-md-color-media data-md-color-scheme=slate data-md-color-primary=indigo data-md-color-accent=indigo aria-label="Switch to light mode" type=radio name=__palette id=__palette_1> <label class="md-header__button md-icon" title="Switch to light mode" for=__palette_0 hidden> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg> </label> </form> <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script> <label class="md-header__button md-icon" for=__search> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg> </label> <div class=md-search data-md-component=search role=dialog> <label class=md-search__overlay for=__search></label> <div class=md-search__inner role=search> <form class=md-search__form name=search> <input type=text class=md-search__input name=query aria-label=Search placeholder=Search autocapitalize=off autocorrect=off autocomplete=off spellcheck=false data-md-component=search-query required> <label class="md-search__icon md-icon" for=__search> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg> </label> <nav class=md-search__options aria-label=Search> <a href=javascript:void(0) class="md-search__icon md-icon" title=Share aria-label=Share data-clipboard data-clipboard-text data-md-component=search-share tabindex=-1> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M18 16.08c-.76 0-1.44.3-1.96.77L8.91 12.7c.05-.23.09-.46.09-.7 0-.24-.04-.47-.09-.7l7.05-4.11c.54.5 1.25.81 2.04.81a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3c0 .24.04.47.09.7L8.04 9.81C7.5 9.31 6.79 9 6 9a3 3 0 0 0-3 3 3 3 0 0 0 3 3c.79 0 1.5-.31 2.04-.81l7.12 4.15c-.05.21-.08.43-.08.66 0 1.61 1.31 2.91 2.92 2.91 1.61 0 2.92-1.3 2.92-2.91A2.92 2.92 0 0 0 18 16.08Z"/></svg> </a> <button type=reset class="md-search__icon md-icon" title=Clear aria-label=Clear tabindex=-1> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg> </button> </nav> <div class=md-search__suggest data-md-component=search-suggest></div> </form> <div class=md-search__output> <div class=md-search__scrollwrap data-md-scrollfix> <div class=md-search-result data-md-component=search-result> <div class=md-search-result__meta> Initializing search </div> <ol class=md-search-result__list role=presentation></ol> </div> </div> </div> </div> </div> </nav> </header> <div class=md-container data-md-component=container> <nav class=md-tabs aria-label=Tabs data-md-component=tabs> <div class=md-grid> <ul class=md-tabs__list> <li class=md-tabs__item> <a href=../.. class=md-tabs__link> Home </a> </li> <li class=md-tabs__item> <a href=../../changelog/ class=md-tabs__link> Changelog </a> </li> <li class=md-tabs__item> <a href=../../forms/ class=md-tabs__link> Forms </a> </li> <li class=md-tabs__item> <a href=../../allergy/food-allergy/allergen-cards/ class=md-tabs__link> Allergy </a> </li> <li class=md-tabs__item> <a href=../../checklists/clinical-allergen-challenge/ class=md-tabs__link> Checklists </a> </li> <li class="md-tabs__item md-tabs__item--active"> <a href=../acute-urticaria/ class=md-tabs__link> Patient information </a> </li> <li class=md-tabs__item> <a href=../../protocols/alutek-immunotherapy/ class=md-tabs__link> Protocols </a> </li> </ul> </div> </nav> <main class=md-main data-md-component=main> <div class="md-main__inner md-grid"> <div class="md-sidebar md-sidebar--primary" data-md-component=sidebar data-md-type=navigation> <div class=md-sidebar__scrollwrap> <div class=md-sidebar__inner> <nav class="md-nav md-nav--primary md-nav--lifted" aria-label=Navigation data-md-level=0> <label class=md-nav__title for=__drawer> <a href=../.. title=Immunowiki class="md-nav__button md-logo" aria-label=Immunowiki data-md-component=logo> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M13 12h7v1.5h-7m0-4h7V11h-7m0 3.5h7V16h-7m8-12H3a2 2 0 0 0-2 2v13a2 2 0 0 0 2 2h18a2 2 0 0 0 2-2V6a2 2 0 0 0-2-2m0 15h-9V6h9"/></svg> </a> Immunowiki </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../.. class=md-nav__link> <span class=md-ellipsis> Home </span> </a> </li> <li class=md-nav__item> <a href=../../changelog/ class=md-nav__link> <span class=md-ellipsis> Changelog </span> </a> </li> <li class=md-nav__item> <a href=../../forms/ class=md-nav__link> <span class=md-ellipsis> Forms </span> </a> </li> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle " type=checkbox id=__nav_4> <label class=md-nav__link for=__nav_4 id=__nav_4_label tabindex> <span class=md-ellipsis> Allergy </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav data-md-level=1 aria-labelledby=__nav_4_label aria-expanded=false> <label class=md-nav__title for=__nav_4> <span class="md-nav__icon md-icon"></span> Allergy </label> <ul class=md-nav__list data-md-scrollfix> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle " type=checkbox id=__nav_4_1> <label class=md-nav__link for=__nav_4_1 id=__nav_4_1_label tabindex> <span class=md-ellipsis> Food allergy </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav data-md-level=2 aria-labelledby=__nav_4_1_label aria-expanded=false> <label class=md-nav__title for=__nav_4_1> <span class="md-nav__icon md-icon"></span> Food allergy </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../allergy/food-allergy/allergen-cards/ class=md-nav__link> <span class=md-ellipsis> Allergen Cards </span> </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle " type=checkbox id=__nav_4_2> <label class=md-nav__link for=__nav_4_2 id=__nav_4_2_label tabindex> <span class=md-ellipsis> Protocols </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav data-md-level=2 aria-labelledby=__nav_4_2_label aria-expanded=false> <label class=md-nav__title for=__nav_4_2> <span class="md-nav__icon md-icon"></span> Protocols </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../allergy/protocols/steroid-skin-testing/ class=md-nav__link> <span class=md-ellipsis> Steroid Testing </span> </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle " type=checkbox id=__nav_4_3> <label class=md-nav__link for=__nav_4_3 id=__nav_4_3_label tabindex> <span class=md-ellipsis> Venoms </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav data-md-level=2 aria-labelledby=__nav_4_3_label aria-expanded=false> <label class=md-nav__title for=__nav_4_3> <span class="md-nav__icon md-icon"></span> Venoms </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../allergy/venoms/letter-to-gp/ class=md-nav__link> <span class=md-ellipsis> Letter to GP </span> </a> </li> <li class=md-nav__item> <a href=../../allergy/venoms/modified-rush-protocol/ class=md-nav__link> <span class=md-ellipsis> Appendix B - Modified Rush Protocol </span> </a> </li> <li class=md-nav__item> <a href=../../allergy/venoms/standard-initiation-protocol/ class=md-nav__link> <span class=md-ellipsis> Appendix A - Standard Initiation Protocol </span> </a> </li> <li class=md-nav__item> <a href=../../allergy/venoms/venom-allergy-testing/ class=md-nav__link> <span class=md-ellipsis> Venom Allergy Testing </span> </a> </li> <li class=md-nav__item> <a href=../../allergy/venoms/venom-immunotherapy-desensitisation/ class=md-nav__link> <span class=md-ellipsis> Venom Immunotherapy / Desensitisation </span> </a> </li> </ul> </nav> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle " type=checkbox id=__nav_5> <label class=md-nav__link for=__nav_5 id=__nav_5_label tabindex> <span class=md-ellipsis> Checklists </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav data-md-level=1 aria-labelledby=__nav_5_label aria-expanded=false> <label class=md-nav__title for=__nav_5> <span class="md-nav__icon md-icon"></span> Checklists </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../checklists/clinical-allergen-challenge/ class=md-nav__link> <span class=md-ellipsis> Clinical Allergen Challenge Checklist </span> </a> </li> <li class=md-nav__item> <a href=../../checklists/methotrexate/ class=md-nav__link> <span class=md-ellipsis> Methotrexate </span> </a> </li> <li class=md-nav__item> <a href=../../checklists/rituximab/ class=md-nav__link> <span class=md-ellipsis> Rituximab Therapy </span> </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--active md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle " type=checkbox id=__nav_6 checked> <label class=md-nav__link for=__nav_6 id=__nav_6_label tabindex> <span class=md-ellipsis> Patient information </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav data-md-level=1 aria-labelledby=__nav_6_label aria-expanded=true> <label class=md-nav__title for=__nav_6> <span class="md-nav__icon md-icon"></span> Patient information </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../acute-urticaria/ class=md-nav__link> <span class=md-ellipsis> Acute Urticaria </span> </a> </li> <li class="md-nav__item md-nav__item--active"> <input class="md-nav__toggle md-toggle" type=checkbox id=__toc> <a href=./ class="md-nav__link md-nav__link--active"> <span class=md-ellipsis> Alemtuzumab </span> </a> </li> <li class=md-nav__item> <a href=../allergic-rhinitis/ class=md-nav__link> <span class=md-ellipsis> Allergic Rhinitis </span> </a> </li> <li class=md-nav__item> <a href=../anaphylaxis/ class=md-nav__link> <span class=md-ellipsis> Anaphylaxis </span> </a> </li> <li class=md-nav__item> <a href=../atopic-dermatitis/ class=md-nav__link> <span class=md-ellipsis> Atopic Dermatitis </span> </a> </li> <li class=md-nav__item> <a href=../avoiding-allergens/ class=md-nav__link> <span class=md-ellipsis> Avoiding Allergens </span> </a> </li> <li class=md-nav__item> <a href=../azathioprine/ class=md-nav__link> <span class=md-ellipsis> Azathioprine </span> </a> </li> <li class=md-nav__item> <a href=../chronic-urticaria/ class=md-nav__link> <span class=md-ellipsis> Chronic Urticaria </span> </a> </li> <li class=md-nav__item> <a href=../ciclosporin/ class=md-nav__link> <span class=md-ellipsis> Ciclosporin </span> </a> </li> <li class=md-nav__item> <a href=../clinical-allergen-challenge/ class=md-nav__link> <span class=md-ellipsis> Clinical Allergen Challenge </span> </a> </li> <li class=md-nav__item> <a href=../cvid/ class=md-nav__link> <span class=md-ellipsis> Common Variable Immune Deficiency (CVID) </span> </a> </li> <li class=md-nav__item> <a href=../cyclophosphamide-therapy/ class=md-nav__link> <span class=md-ellipsis> Cyclophosphamide Therapy </span> </a> </li> <li class=md-nav__item> <a href=../hydroxychloroquine/ class=md-nav__link> <span class=md-ellipsis> Hydroxychloroquine </span> </a> </li> <li class=md-nav__item> <a href=../immunoglobulin-replacement-therapy/ class=md-nav__link> <span class=md-ellipsis> Immunoglobulin Replacement Therapy </span> </a> </li> <li class=md-nav__item> <a href=../latex-allergy/ class=md-nav__link> <span class=md-ellipsis> Latex Allergy </span> </a> </li> <li class=md-nav__item> <a href=../methotrexate/ class=md-nav__link> <span class=md-ellipsis> Methotrexate </span> </a> </li> <li class=md-nav__item> <a href=../mycophenolate/ class=md-nav__link> <span class=md-ellipsis> Mycophenolate </span> </a> </li> <li class=md-nav__item> <a href=../omalizumab/ class=md-nav__link> <span class=md-ellipsis> Omalizumab </span> </a> </li> <li class=md-nav__item> <a href=../onj/ class=md-nav__link> <span class=md-ellipsis> Osteonecrosis of the Jaw (ONJ) </span> </a> </li> <li class=md-nav__item> <a href=../penicillin-allergy-testing/ class=md-nav__link> <span class=md-ellipsis> Penicillin Allergy Testing </span> </a> </li> <li class=md-nav__item> <a href=../prednisone/ class=md-nav__link> <span class=md-ellipsis> Prednisone </span> </a> </li> <li class=md-nav__item> <a href=../preparing-for-immunosuppression/ class=md-nav__link> <span class=md-ellipsis> Preparing for Immunosuppresion </span> </a> </li> <li class=md-nav__item> <a href=../risendronate/ class=md-nav__link> <span class=md-ellipsis> Risendronate (Actonel) </span> </a> </li> <li class=md-nav__item> <a href=../rituximab/ class=md-nav__link> <span class=md-ellipsis> Rituximab </span> </a> </li> <li class=md-nav__item> <a href=../sjogrens-syndrome/ class=md-nav__link> <span class=md-ellipsis> Sjögren’s Syndrome </span> </a> </li> <li class=md-nav__item> <a href=../sle/ class=md-nav__link> <span class=md-ellipsis> Systemic Lupus Erythematosus (SLE) </span> </a> </li> <li class=md-nav__item> <a href=../steroid-withdrawal/ class=md-nav__link> <span class=md-ellipsis> Steroid Withdrawal </span> </a> </li> <li class=md-nav__item> <a href=../steroids-and-osteoporosis/ class=md-nav__link> <span class=md-ellipsis> Steroids and Osteoporosis </span> </a> </li> <li class=md-nav__item> <a href=../subcutaneous-immunotherapy/ class=md-nav__link> <span class=md-ellipsis> Subcutaneous Immunoglobulin Therapy </span> </a> </li> <li class=md-nav__item> <a href=../tnf-inhibitors/ class=md-nav__link> <span class=md-ellipsis> Tumour Necrosis Factor (TNF) Inhibitors </span> </a> </li> <li class=md-nav__item> <a href=../wet-dressings/ class=md-nav__link> <span class=md-ellipsis> Wet Dressings </span> </a> </li> <li class=md-nav__item> <a href=../zolendronate/ class=md-nav__link> <span class=md-ellipsis> Zolendronate </span> </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle " type=checkbox id=__nav_7> <label class=md-nav__link for=__nav_7 id=__nav_7_label tabindex> <span class=md-ellipsis> Protocols </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav data-md-level=1 aria-labelledby=__nav_7_label aria-expanded=false> <label class=md-nav__title for=__nav_7> <span class="md-nav__icon md-icon"></span> Protocols </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../protocols/alutek-immunotherapy/ class=md-nav__link> <span class=md-ellipsis> Alutek Immunotherapy </span> </a> </li> <li class=md-nav__item> <a href=../../protocols/anaphylaxis/ class=md-nav__link> <span class=md-ellipsis> Background </span> </a> </li> <li class=md-nav__item> <a href=../../protocols/aspirin-desensitisation-rapid/ class=md-nav__link> <span class=md-ellipsis> Background </span> </a> </li> <li class=md-nav__item> <a href=../../protocols/aspirin-desensitisation/ class=md-nav__link> <span class=md-ellipsis> Aspirin Desensitisation Protocol </span> </a> </li> <li class=md-nav__item> <a href=../../protocols/immunosuppression-screen/ class=md-nav__link> <span class=md-ellipsis> Immunosuppression Screen </span> </a> </li> <li class=md-nav__item> <a href=../../protocols/offlabel-nmo-and-mg/ class=md-nav__link> <span class=md-ellipsis> Prescribing Rituximab Off-label for NMO and Myasthenia Patients </span> </a> </li> <li class=md-nav__item> <a href=../../protocols/protocol-cyclophosphamide/ class=md-nav__link> <span class=md-ellipsis> Protocol for Pulsed IV Cyclophosphamide Immunosuppression </span> </a> </li> <li class=md-nav__item> <a href=../../protocols/rituximab-infusion-protocol/ class=md-nav__link> <span class=md-ellipsis> Rituximab Infusion Protocols </span> </a> </li> <li class=md-nav__item> <a href=../../protocols/venom-immunotherapy/ class=md-nav__link> <span class=md-ellipsis> Modified Rush Protocol for Venom Immunotherapy </span> </a> </li> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle " type=checkbox id=__nav_7_10> <label class=md-nav__link for=__nav_7_10 id=__nav_7_10_label tabindex> <span class=md-ellipsis> Drug allergy </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav data-md-level=2 aria-labelledby=__nav_7_10_label aria-expanded=false> <label class=md-nav__title for=__nav_7_10> <span class="md-nav__icon md-icon"></span> Drug allergy </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../protocols/drug-allergy/penicillin-testing/ class=md-nav__link> <span class=md-ellipsis> Penicillin Testing Protocol </span> </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--section md-nav__item--nested"> <input class="md-nav__toggle md-toggle " type=checkbox id=__nav_7_11> <label class=md-nav__link for=__nav_7_11 id=__nav_7_11_label tabindex> <span class=md-ellipsis> Prednisone </span> <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav data-md-level=2 aria-labelledby=__nav_7_11_label aria-expanded=false> <label class=md-nav__title for=__nav_7_11> <span class="md-nav__icon md-icon"></span> Prednisone </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../protocols/prednisone/3monthschedule/ class=md-nav__link> <span class=md-ellipsis> Prednisone - 3-4 month weaning schedule </span> </a> </li> <li class=md-nav__item> <a href=../../protocols/prednisone/reduced-dose-regimen-50to75kg/ class=md-nav__link> <span class=md-ellipsis> (50-75kg) Prednisone Reduced-dose Regimen </span> </a> </li> <li class=md-nav__item> <a href=../../protocols/prednisone/reduced-dose-regimen-all/ class=md-nav__link> <span class=md-ellipsis> (All) Prednisone Reduced-dose Regimen </span> </a> </li> <li class=md-nav__item> <a href=../../protocols/prednisone/reduced-dose-regimen-over50kg/ class=md-nav__link> <span class=md-ellipsis> (>75kg) Prednisone Reduced-dose Regimen </span> </a> </li> <li class=md-nav__item> <a href=../../protocols/prednisone/reduced-dose-regimen-under50kg/ class=md-nav__link> <span class=md-ellipsis> (<50kg) Prednisone Reduced-dose Regimen </span> </a> </li> </ul> </nav> </li> </ul> </nav> </li> </ul> </nav> </div> </div> </div> <div class="md-sidebar md-sidebar--secondary" data-md-component=sidebar data-md-type=toc> <div class=md-sidebar__scrollwrap> <div class=md-sidebar__inner> <nav class="md-nav md-nav--secondary" aria-label="Table of contents"> </nav> </div> </div> </div> <div class=md-content data-md-component=content> <article class="md-content__inner md-typeset"> <h1 id=why-is-alemtuzumab-being-recommended-in-my-condition>Why is Alemtuzumab being recommended in my condition?<a class=headerlink href=#why-is-alemtuzumab-being-recommended-in-my-condition title="Permanent link">&para;</a></h1> <p>You have been diagnosed with an autoimmune inflammatory condition of the immune system. "Autoimmune" means that the immune system has started to attack one or more organs of the body causing inflammation and tissue damage. Alemtuzumab is a strong medicine designed to specifically target the parts of the immune system that are involved in generating that attack. Alemtuzumab is only recommended when the benefits of treatment are likely to outweigh the risks of leaving the condition untreated.</p> <h1 id=about-alemtuzumab>About Alemtuzumab<a class=headerlink href=#about-alemtuzumab title="Permanent link">&para;</a></h1> <p>Alemtuzumab was developed to treat people with a form of blood cancer (CLL), but it is increasingly used for autoimmune diseases, mainly multiple sclerosis (MS). The dose and frequency of alemtuzumab treatment used for MS are much lower than when it is used to treat cancer.</p> <h1 id=multiple-sclerosis-ms>Multiple Sclerosis (MS)<a class=headerlink href=#multiple-sclerosis-ms title="Permanent link">&para;</a></h1> <p>MS is one form of autoimmune inflammatory disease of the immune system. The target in this case is cells in the brain and spinal cord. Alemtuzumab has been used as an experimental treatment of MS since 1991. Several studies have shown that it is effective. For instance, one trial compared alemtuzumab to interferon-beta (Rebif), in people with relapsing-remitting MS. This trial was called "CAMMS223". Alemtuzumab reduced progression of disability as well as the risk of having a relapse by over two thirds. There were more side-effects associated with Alemtuzumab.</p> <h1 id=is-alemtuzumab-suitable-for-me>Is Alemtuzumab suitable for me?<a class=headerlink href=#is-alemtuzumab-suitable-for-me title="Permanent link">&para;</a></h1> <p>We will take you through a risk assessment process before prescribing Alemtuzumab that will help us identify any particular concerns about the use of this medication in your case.</p> <h1 id=how-is-alemtuzumab-given>How is Alemtuzumab given?<a class=headerlink href=#how-is-alemtuzumab-given title="Permanent link">&para;</a></h1> <p>Alemtuzumab is given as an infusion into a vein in your arm over four hours. These infusions are mostly given in hospital as an inpatient.</p> <p>For the first course of alemtuzumab, you will have an infusion (12 mg) every day for five consecutive days. There is no further alemtuzumab until at least 12 months later, when you will receive a similar daily infusion but for three days only. The need for subsequent infusions will be assessed on an individual patient basis. Sometimes this will involve further MRI scans to obtain information.</p> <p>You will also receive an intravenous course of steroids (methylprednisolone) given as an infusion for approximately 1 hour just before each dose of alemtuzumab.</p> <h1 id=what-are-the-side-effects-of-alemtuzumab>What are the side-effects of Alemtuzumab?<a class=headerlink href=#what-are-the-side-effects-of-alemtuzumab title="Permanent link">&para;</a></h1> <p>The risks described below are the well known ones based upon experience in clinical trials.</p> <h2 id=infusion-related-risks>Infusion-related risks<a class=headerlink href=#infusion-related-risks title="Permanent link">&para;</a></h2> <p>The first or second dose of alemtuzumab may be associated with the symptoms listed below. Your doctor will give you an antihistamine and paracetamol, as well as IV steroids, before the alemtuzumab infusion to reduce the side effects further. The possible side effects are</p> <ul> <li>Worsening of current or old symptoms from MS. This lasts only for a few hours and does not lead to permanently increased disability.</li> <li>Rash (raised itchy red spots on the skin) which can be treated with anti histamine medication.</li> <li>Fever, headache, and fatigue -- may last for a few hours.</li> <li>Rigor/chills (feeling cold and shaking).</li> <li>Nausea, vomiting, and/or diarrhoea -- this happens rarely.</li> <li>Shortness of breath and/or spasms in the windpipe, especially in patients with asthma.</li> <li>A drop in blood pressure that may cause dizziness, headache and fatigue.</li> </ul> <h2 id=risk-of-bleeding-from-a-low-platelet-count>Risk of bleeding from a Low Platelet Count<a class=headerlink href=#risk-of-bleeding-from-a-low-platelet-count title="Permanent link">&para;</a></h2> <p>Alemtuzumab treatment in people with MS has been associated with a low platelet count (called "thrombocytopenia"). Platelets help form blood clots. Therefore a low platelet count may lead to an increased risk of bleeding, and so can cause easy bruising, bleeding of the gums, nosebleeds, unusually heavy menstrual periods, or any other unusual bruising or bleeding. There have been some confirmed cases of thrombocytopenia (low platelet count) among alemtuzumab-treated patients (less than 5% of patients) which can occur for some years after treatment. To identify any fall in platelets as early as possible, all people treated with alemtuzumab must have monthly blood tests for 5 years. If the platelet count drops significantly or goes down to a low level, the blood tests will be done on a weekly basis for at least 8 weeks until the platelet count stops decreasing or until it starts increasing and then monthly blood tests for three years after receiving alemtuzumab.</p> <h2 id=increased-risk-of-infection>Increased Risk of Infection<a class=headerlink href=#increased-risk-of-infection title="Permanent link">&para;</a></h2> <h2 id=listeria>Listeria<a class=headerlink href=#listeria title="Permanent link">&para;</a></h2> <p>For the first few months after Alemtuzumab, there is an increased risk of infections from a bacteria called Listeria from unpasteurised milk products. If severe, these might need hospital treatment and have the potential to lead to death. The risk of Listeria can be reduced significantly by following simple dietary advice (foods to avoid). You will be provided with a list of foods to avoid.</p> <p>Autoimmune neutropenia, a decrease in white blood cells can occur and this too can increase the risk to certain infections. This results from a similar mechanism to the low platelet count and can occur years after the infusion. The monthly blood counts will also help identify low white blood cells. </p> <h2 id=varicella-chicken-pox-or-shingles>Varicella (chicken pox or shingles)<a class=headerlink href=#varicella-chicken-pox-or-shingles title="Permanent link">&para;</a></h2> <p>Over the next few months, there is also an increased risk of viral infections such as shingles or measles. If you receive alemtuzumab, you should avoid contact with anyone who has symptoms of chicken pox or shingles. If you are exposed to these infections, please notify your doctor as soon as possible. Preferably patients should be confirmed to have had chickenpox exposure or be vaccinated prior to treatment with alemtuzumab. Currently available chickenpox vaccines are not safe after treatment with alemtuzumab, at least for many months. Patients with previous chickenpox or vaccination are still at risk of shingles. This usually presents with an intense band of pain followed by a rash in the skin affected on one side of the body, anywhere on the body. If you think you may be developing shingles after treatment with alemtuzumab, please notify your MS centre, as early administration of antiviral medication can reduce the severity of symptoms.</p> <h2 id=herpes-simplex-type-1-and-2>Herpes Simplex Type 1 and 2<a class=headerlink href=#herpes-simplex-type-1-and-2 title="Permanent link">&para;</a></h2> <p>If you have a history of herpes infections (cold sores or genital herpes), they may recur following treatment with alemtuzumab. If you experience cold sores, a herpes outbreak, or have any unexplained rash, please contact your doctor since anti-viral medicines are available that can reduce the severity of the outbreak. A preventative anti-viral medication is usually given for the first month after treatment with alemtuzumab.</p> <h2 id=human-papilloma-virus-cervical-dysplasia>Human Papilloma Virus (Cervical Dysplasia)<a class=headerlink href=#human-papilloma-virus-cervical-dysplasia title="Permanent link">&para;</a></h2> <p>Women infected with human Papilloma virus (HPV) are at increased risk for cervical cancer. That risk may increase after immune suppression by alemtuzumab. A gynaecological exam with Papanicolaou (Pap) smear and HPV screening performed within a year prior to the start of alemtuzumab treatment is strongly recommended for all women. An annual gynaecological exam with Pap smear and HPV screening is strongly recommended for all women.</p> <h2 id=vaccinations>Vaccinations<a class=headerlink href=#vaccinations title="Permanent link">&para;</a></h2> <blockquote> <p class=is-warning>You should not receive a live vaccine. </p> </blockquote> <p>The routine influenza (flu) vaccine is however both safe and recommended.  It is important that you check with your doctor before receiving any vaccine. If your doctor is unsure they can contact the MS centre.</p> <h2 id=thyroid-problems>Thyroid problems<a class=headerlink href=#thyroid-problems title="Permanent link">&para;</a></h2> <p>There is up to 30% chance of developing a disease of the thyroid gland, most commonly an overactive thyroid gland (Graves' disease). If untreated, the symptoms of Graves' disease would be: increased sweating, anxiety, weight loss, tremor and sometimes pain in the neck. If needed, the first treatment is tablets. These are normally given for 6 months and then stopped. If the thyroid gland still remains overactive, it can be permanently suppressed by radioactive iodine treatment. After radioactive treatment, it is usually necessary to take thyroid tablets for life. One symptom of Graves' disease that may not be easily controlled by tablets is swelling of the eyes. This progressive swelling may look unpleasant and may even compromise vision. It may require treatment with steroids, radiotherapy or surgery. We will refer anyone with thyroid disease to a local specialist.</p> <h2 id=goodpastures-syndrome>Goodpasture's Syndrome<a class=headerlink href=#goodpastures-syndrome title="Permanent link">&para;</a></h2> <p>This is a very rare disease that affects the lungs and kidneys. It often leads to kidney failure and the need for dialysis or even kidney transplantation. Treatment can be effective if begun very early and consists of washing the blood ("plasma exchange") and powerful drugs like prednisolone, cyclophosphamide or azathioprine.</p> <h2 id=risks-associated-with-methylprednisolone>Risks Associated with Methylprednisolone<a class=headerlink href=#risks-associated-with-methylprednisolone title="Permanent link">&para;</a></h2> <p>People taking methylprednisolone can experience an unpleasant taste in the mouth, tingling in their limbs, difficulty sleeping and a burst of energy. Rarely stomach bleeds can happen. These symptoms all resolve soon after infusion.</p> <h1 id=fertility-and-harm-to-the-unborn-child>Fertility and Harm to the Unborn Child<a class=headerlink href=#fertility-and-harm-to-the-unborn-child title="Permanent link">&para;</a></h1> <p>There is no information available about the effects of alemtuzumab on fertility and pregnancies, and it is potentially harmful. There is a possibility that alemtuzumab might transiently reduce or affect fertility in both men and women.</p> <p>Alemtuzumab may be harmful to an unborn child. Pregnant or breastfeeding women should not take alemtuzumab. Both men and women who are capable of childbearing should use an effective form of birth control for 12 months after each dose of Alemtuzumab. If you become pregnant, you should notify your doctor and let your MS specialist know so that management of the pregnancy can be discussed.</p> <h1 id=risks-of-combining-alemtuzumab-with-other-drugs>Risks of combining Alemtuzumab with other drugs<a class=headerlink href=#risks-of-combining-alemtuzumab-with-other-drugs title="Permanent link">&para;</a></h1> <p>We do not know all the side effects that may arise from the combination of alemtuzumab with other drugs so you should always discuss the use of any drugs (over-the-counter, prescription, illegal, herbal or nutritional supplement) with your doctor or pharmacist.</p> <h1 id=what-do-i-need-to-do-after-having-had-alemtuzumab>What Do I need to do after having had Alemtuzumab?<a class=headerlink href=#what-do-i-need-to-do-after-having-had-alemtuzumab title="Permanent link">&para;</a></h1> <p>For the first 2 weeks after treatment with Alemtuzumab, you may experience more fatigue than you are used to. For the next 12 weeks, you are at special risk of infections. Simple colds and viral infections are common and will be no different in severity or duration if you catch them. Please let your GP and your MS specialist know if you think you may have an infection.</p> <p>For three months, avoid food that might contain Listeria (see below). If you are on other medication, please check with your doctor or pharmacist first. It is best to avoid herbal or alternative remedies. If you see a doctor or nurse about any health issue, make sure that they know you have received alemtuzumab.</p> <p>Do not have live vaccinations. Make sure adequate vaccinations as usual are in place before foreign travel. Travel to countries where infections such as tuberculosis are common is not recommended.</p> <p>Please ensure that you have a monthly blood test to check your platelet count. Look out for signs and symptoms of a low platelet count: easy bruising, bleeding of the gums, nosebleeds, unusually heavy menstrual periods, or any other unusual bruising or bleeding. If you have any of these, you must seek attention within 24 hours. Please contact your GP. We will ask you to get a "full blood count" test as soon as possible. This blood test is widely available. If you cannot contact your GP, the safest thing to do is to go to your nearest A&amp;E Department and show them this document and explain your concerns.</p> <hr> <p><strong>Updated 2013</strong></p> </article> </div> <script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script> </div> <button type=button class="md-top md-icon" data-md-component=top hidden> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg> Back to top </button> </main> <footer class=md-footer> <div class="md-footer-meta md-typeset"> <div class="md-footer-meta__inner md-grid"> <div class=md-copyright> <div class=md-copyright__highlight> 2023 Department of Immunology </div> </div> <div class=md-social> <a href=https://liam.immunowiki.com target=_blank rel=noopener title=liam.immunowiki.com class=md-social__link> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 496 512"><!-- Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg> </a> <a href=https://liam.immunowiki.com target=_blank rel=noopener title=liam.immunowiki.com class=md-social__link> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 384 512"><!-- Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M66.4 322.5H16V0h50.4v322.5zM166.9 76.1h-50.4V512h50.4V76.1zm100.6 0h-50.4V512h50.4V76.1zM368 76h-50.4v247H368V76z"/></svg> </a> <a href=https://liam.immunowiki.com target=_blank rel=noopener title=liam.immunowiki.com class=md-social__link> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 640 512"><!-- Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M349.9 236.3h-66.1v-59.4h66.1v59.4zm0-204.3h-66.1v60.7h66.1V32zm78.2 144.8H362v59.4h66.1v-59.4zm-156.3-72.1h-66.1v60.1h66.1v-60.1zm78.1 0h-66.1v60.1h66.1v-60.1zm276.8 100c-14.4-9.7-47.6-13.2-73.1-8.4-3.3-24-16.7-44.9-41.1-63.7l-14-9.3-9.3 14c-18.4 27.8-23.4 73.6-3.7 103.8-8.7 4.7-25.8 11.1-48.4 10.7H2.4c-8.7 50.8 5.8 116.8 44 162.1 37.1 43.9 92.7 66.2 165.4 66.2 157.4 0 273.9-72.5 328.4-204.2 21.4.4 67.6.1 91.3-45.2 1.5-2.5 6.6-13.2 8.5-17.1l-13.3-8.9zm-511.1-27.9h-66v59.4h66.1v-59.4zm78.1 0h-66.1v59.4h66.1v-59.4zm78.1 0h-66.1v59.4h66.1v-59.4zm-78.1-72.1h-66.1v60.1h66.1v-60.1z"/></svg> </a> <a href=https://liam.immunowiki.com target=_blank rel=noopener title=liam.immunowiki.com class=md-social__link> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 512 512"><!-- Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"/></svg> </a> <a href=https://liam.immunowiki.com target=_blank rel=noopener title=liam.immunowiki.com class=md-social__link> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 448 512"><!-- Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z"/></svg> </a> <a href=https://liam.immunowiki.com target=_blank rel=noopener title=liam.immunowiki.com class=md-social__link> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 448 512"><!-- Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M224.1 141c-63.6 0-114.9 51.3-114.9 114.9s51.3 114.9 114.9 114.9S339 319.5 339 255.9 287.7 141 224.1 141zm0 189.6c-41.1 0-74.7-33.5-74.7-74.7s33.5-74.7 74.7-74.7 74.7 33.5 74.7 74.7-33.6 74.7-74.7 74.7zm146.4-194.3c0 14.9-12 26.8-26.8 26.8-14.9 0-26.8-12-26.8-26.8s12-26.8 26.8-26.8 26.8 12 26.8 26.8zm76.1 27.2c-1.7-35.9-9.9-67.7-36.2-93.9-26.2-26.2-58-34.4-93.9-36.2-37-2.1-147.9-2.1-184.9 0-35.8 1.7-67.6 9.9-93.9 36.1s-34.4 58-36.2 93.9c-2.1 37-2.1 147.9 0 184.9 1.7 35.9 9.9 67.7 36.2 93.9s58 34.4 93.9 36.2c37 2.1 147.9 2.1 184.9 0 35.9-1.7 67.7-9.9 93.9-36.2 26.2-26.2 34.4-58 36.2-93.9 2.1-37 2.1-147.8 0-184.8zM398.8 388c-7.8 19.6-22.9 34.7-42.6 42.6-29.5 11.7-99.5 9-132.1 9s-102.7 2.6-132.1-9c-19.6-7.8-34.7-22.9-42.6-42.6-11.7-29.5-9-99.5-9-132.1s-2.6-102.7 9-132.1c7.8-19.6 22.9-34.7 42.6-42.6 29.5-11.7 99.5-9 132.1-9s102.7-2.6 132.1 9c19.6 7.8 34.7 22.9 42.6 42.6 11.7 29.5 9 99.5 9 132.1s2.7 102.7-9 132.1z"/></svg> </a> </div> </div> </div> </footer> </div> <div class=md-dialog data-md-component=dialog> <div class="md-dialog__inner md-typeset"></div> </div> <script id=__config type=application/json>{"base": "../..", "features": ["content.code.annotate", "navigation.indexes", "navigation.sections", "navigation.tabs", "navigation.top", "navigation.tracking", "search.share", "search.suggest", "announce.dismiss", "content.tooltips"], "search": "../../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script> <script src=../../assets/javascripts/bundle.c18c5fb9.min.js></script> </body> </html>